Status:
COMPLETED
Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
Lead Sponsor:
University Hospital, Antwerp
Collaborating Sponsors:
Bristol-Myers Squibb
Universiteit Antwerpen
Conditions:
Atrial Fibrillation and Flutter
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate a new and innovative educational application based on targeted education on the adherence level for NOACs (non-vitamin K antagonist oral anticoagulants) in AF pati...
Detailed Description
This substudy is part of the AF-EduCare study (NCT03707873): an extra study arm will be added to the main trial in which eligible AF patients (= in possession of a smartphone and capable working with ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, holter,...).
- Patients who are capable to sign the informed consent.
Exclusion
- Not able to speak and read Dutch.
- Cognitive impaired (e.g. severe dementia).
- Life expectancy is estimated to be less than 1 year.
- Ongoing participation in another clinical trial.
- Pregnant women
Key Trial Info
Start Date :
October 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT03788044
Start Date
October 28 2019
End Date
September 30 2022
Last Update
November 3 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp University Hospital
Edegem, Belgium
2
Jessa Hospital
Hasselt, Belgium